Fact CheckerSign in

NCT07020637Completed

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

Source: ClinicalTrials.gov · Last updated 14 Jul 2026

Brief summary (registry, in English)

This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.

Status (registry)
Completed
Study type
Observational
Enrollment
30 (actual)
First submitted
5 Jun 2025
Start date
19 Oct 2024
Primary completion date
30 Apr 2026
Lead sponsor
University of Nevada, Las Vegas
Diseases
Stroke
NCT number
NCT07020637

What you commit to

  • Study type: Observational
  • Participants enrolled: 30
  • From 19 Oct 2024 to the primary completion date, 30 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known severe aortic valve disease or dynamic left ventricular outflow tract obstruction
  • Morbid obesity (BMI \> 40) that precludes accurate echocardiographic imaging Presence of cardiac arrhythmias (e.g., atrial fibrillation with rapid ventricular response) affecting stroke volume measurements
  • Implanted cardiac assist devices (e.g., LVAD, pacemaker dependency)

Other

  • Pregnancy
  • Imminent death or decision for comfort care only

Who the study is looking for

  • Age ≥ 18 years
  • Clinical diagnosis of shock as determined by the treating ICU physician (e.g., hypotension requiring vasopressors or evidence of end-organ hypoperfusion)
  • Able to obtain informed consent from the patient or a legally authorized representative
  • Enrollment within 24 hours of ICU admission

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Medical Center Southern Nevada
Coordinator of this site? Confirm its status
Las VegasUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.